Aehr Test Systems (AEHR) Earnings Date & Reports

Key Takeaways

• Aehr Test Systems (AEHR) reports results for its first quarter of fiscal 2027, ended September 25, 2026, on Monday, November 2, 2026, after the market close.
• Wall Street consensus calls for earnings of about $0.11 per share on revenue of roughly $26.6 million, a sharp jump from $0.01 per share and $11.0 million in the year-ago quarter.
• The company enters the report with a record backlog, backed by strong artificial intelligence (AI) and silicon photonics demand.
• Management has guided full-year fiscal 2027 revenue to a range of $130 million to $150 million, implying roughly 160% to 200% growth.
• Shares surged about 30% after the prior quarter's beat, leaving elevated expectations heading into this print.

Earnings Context and Why It Matters

Aehr Test Systems designs test and burn-in systems used to screen semiconductors for AI processors, silicon photonics, data center infrastructure, and automotive applications. This report is the company's first under its newly shifted fiscal calendar, which now ends in June instead of May, making the quarterly comparison an important checkpoint for investors. The print matters because Aehr is transitioning from a challenging fiscal 2026, when revenue declined, into a period management expects to deliver explosive growth. With a record backlog and AI-driven demand for its wafer-level and package-level burn-in platforms, this quarter will test whether the company can convert its order momentum into the revenue acceleration the market is now pricing in.

Earnings Expectations

Analysts expect Aehr Test Systems to report first-quarter fiscal 2027 earnings of approximately $0.11 per share on revenue of about $26.6 million. That would represent a substantial improvement over the year-ago quarter, when the company posted earnings of $0.01 per share on $11.0 million in revenue.

Investors will be watching more than the headline numbers. Bookings and backlog are the key leading indicators for this business, since they signal future revenue visibility. In its fiscal 2026 fourth quarter, Aehr posted a record $60.7 million in quarterly bookings and ended the year with a backlog of roughly $80.6 million, or about $100.6 million including orders received after quarter-end. Management has said the bulk of its fiscal 2027 outlook is supported by existing customers, which raises the bar for any new customer wins announced alongside results.

Gross margin will also be in focus. Non-GAAP (non-Generally Accepted Accounting Principles) gross margin reached 45% in the prior quarter, up 1,000 basis points year over year, and investors will look for confirmation that the favorable product mix can be sustained. Historically, Aehr has beaten consensus earnings estimates in six of its last eight quarters, and its stock reacted sharply after the most recent report, a pattern that raises expectations for this event.

AI Screener

For investors tracking earnings-driven moves across the semiconductor and technology sectors, Tickeron's AI Screener offers an AI-powered stock and exchange-traded fund (ETF) discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener can help identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For those looking to streamline their research around events like quarterly earnings, the AI Screener provides a practical starting point for narrowing the universe of potential opportunities.

Market Reaction and Investor Sentiment

Sentiment heading into Aehr Test Systems' first-quarter report is optimistic but demanding. The stock climbed roughly 30% in a single session after the company's fiscal fourth-quarter results exceeded Wall Street expectations and management issued a stronger-than-anticipated outlook for fiscal 2027. That rally reflects growing conviction in Aehr's position within the AI data center buildout, particularly its wafer-level burn-in and package-level Sonoma systems.

Because much of that enthusiasm is already reflected in the share price, the market reaction will likely hinge less on whether the company meets estimates and more on the trajectory of bookings, backlog, and commentary around new customer programs. Key risk factors include the cyclical and lumpy nature of semiconductor equipment orders, supply chain constraints on components such as power supplies, and ongoing patent litigation costs. Any indication that AI-related demand is moderating, or that orders are slipping beyond the current quarter, could pressure the stock despite solid headline results.

Forward Outlook and Key Factors to Monitor

The central question following this earnings event is whether Aehr Test Systems can sustain the momentum required to hit its fiscal 2027 revenue guidance of $130 million to $150 million. That target implies a dramatic acceleration from fiscal 2026's $50 million in revenue, so investors should monitor whether bookings and backlog continue to build rather than merely hold steady.

One area to watch is the mix between wafer-level burn-in (WLBI) and package-level systems. Aehr's lead AI production customer is shifting from system-level to wafer-level screening, which could influence both revenue timing and margins. Meanwhile, the company is pursuing a second, higher-power device with its lead hyperscale customer, a development that could meaningfully expand its Sonoma system footprint if it converts into production orders.

Silicon photonics is another important demand signal, as AI data center architectures increasingly rely on optical interconnects. Aehr has cited follow-on orders and forecasts from networking customers that suggest this segment could become a longer-term growth driver. Investors may also watch for any commentary on memory applications, such as NAND flash or high-bandwidth memory (HBM), which are currently excluded from guidance but represent potential upside.

Finally, execution and capacity will matter. The company has expanded manufacturing through a contract partner in Southeast Asia to support more than 20 additional systems per month, and management has indicated existing capacity can support revenue above the top end of its guidance. Signs that Aehr can scale without sacrificing gross margin or overbuilding fixed costs will be an important factor in how the market evaluates the stock over the coming quarters.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations